◆英語タイトル:CooperSurgical Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011061
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月21日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
CooperSurgical Inc (CooperSurgical), a subsidiary of The Cooper Companies Inc is a medical device company that offers surgical instrument. The company offers surgical products, clinic and office products, labor and delivery products, and critical care products. Its surgical products include c-section retractors, female sterilization, hernia repair, hysterectomy instruments, laparoscopic instruments, pelvic procedure kits, self-retaining retractors, uterine manipulation devices, and wound protection. CooperSurgical offers labor and delivery products such as amniotic hooks, c-section retractors, c-section safety scalpel, episiotomy retractors, female sterilization, fetal monitoring bands, neonatal care, vacuum-assisted delivery systems. The company also operates its education and support centers for its customers. It serves clinicians, supply chain professionals, healthcare administrators, and others. The company has presence in the US, Germany, the Netherlands and Denmark. CooperSurgical is headquartered in Trumbull, Connecticut, the US.
CooperSurgical Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CooperSurgical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
CooperSurgical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
CooperSurgical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
CooperSurgical Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
CooperSurgical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
CooperSurgical Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
CooperSurgical Acquires PARAGARD from Teva Pharma for USD1.1 Billion 10
CooperSurgical Acquires Wallace Product Line from Smiths Medical International for USD175.2 Million 12
CooperSurgical Acquires Assets of Recombine for USD85 Million 13
Venture Financing 14
Endosee Raises Additional USD0.8 Million in Venture Financing 14
Endosee Raises USD1 Million in Venture Financing 15
Partnerships 16
Reprogenetics Enters into R&D Agreement with Illumina for Next-Generation In-Vitro Fertilization Sequencing Systems 16
Blood Cell Storage Enters Into Agreement With Origio To Advance pH Monitoring For IVF 17
Equity Offering 18
Origio Completes Private Placement Of Common Stock For US$6.5 Million 18
Origio Completes Private Placement For US$0.4 Million 19
Asset Transactions 20
Swissray Acquires Norland Assets From Cooper Surgical 20
Acquisition 21
CooperSurgical Acquires Research Instruments for USD51 Million 21
CooperSurgical Acquires Reprogenetics for USD46.5 Million 22
CooperSurgical Acquires Endosee for USD44 Million 23
Cooper Companies Acquires 96.99% Stake In Origio, Maker Of In-Vitro Fertilization Devices 24
Origio Completes Acquisition Of Minority Stake Of In Trivector Scientific For US$1 Million 26
Origio Acquires Remaining 49% Stake In Origio ScanLab Equipment From LaboGene 27
Origio Acquires Artworks For US$4.3 Million 28
ORIGIO Acquires Incept BioSystems 29
CooperSurgical Inc – Key Competitors 30
CooperSurgical Inc – Key Employees 31
CooperSurgical Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Legal and Regulatory 33
Mar 08, 2017: CooperGenomics Receives ISO 15189 Accreditation in United Kingdom Laboratories for Noninvasive Prenatal Testing 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34
List of Tables
CooperSurgical Inc, Medical Equipment, Key Facts 2
CooperSurgical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
CooperSurgical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
CooperSurgical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
CooperSurgical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
CooperSurgical Inc, Deals By Market, 2011 to YTD 2017 8
CooperSurgical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
CooperSurgical Acquires PARAGARD from Teva Pharma for USD1.1 Billion 10
CooperSurgical Acquires Wallace Product Line from Smiths Medical International for USD175.2 Million 12
CooperSurgical Acquires Assets of Recombine for USD85 Million 13
Endosee Raises Additional USD0.8 Million in Venture Financing 14
Endosee Raises USD1 Million in Venture Financing 15
Reprogenetics Enters into R&D Agreement with Illumina for Next-Generation In-Vitro Fertilization Sequencing Systems 16
Blood Cell Storage Enters Into Agreement With Origio To Advance pH Monitoring For IVF 17
Origio Completes Private Placement Of Common Stock For US$6.5 Million 18
Origio Completes Private Placement For US$0.4 Million 19
Swissray Acquires Norland Assets From Cooper Surgical 20
CooperSurgical Acquires Research Instruments for USD51 Million 21
CooperSurgical Acquires Reprogenetics for USD46.5 Million 22
CooperSurgical Acquires Endosee for USD44 Million 23
Cooper Companies Acquires 96.99% Stake In Origio, Maker Of In-Vitro Fertilization Devices 24
Origio Completes Acquisition Of Minority Stake Of In Trivector Scientific For US$1 Million 26
Origio Acquires Remaining 49% Stake In Origio ScanLab Equipment From LaboGene 27
Origio Acquires Artworks For US$4.3 Million 28
ORIGIO Acquires Incept BioSystems 29
CooperSurgical Inc, Key Competitors 30
CooperSurgical Inc, Key Employees 31
CooperSurgical Inc, Subsidiaries 32